Compare VRAX & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRAX | MYSZ |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United Kingdom | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 972.3K | 869.6K |
| IPO Year | 2021 | 2017 |
| Metric | VRAX | MYSZ |
|---|---|---|
| Price | $0.61 | $0.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 537.1K | 58.8K |
| Earning Date | 11-20-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,000.00 |
| Revenue This Year | N/A | $38.86 |
| Revenue Next Year | N/A | $9.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 125.40 |
| 52 Week Low | $0.10 | $0.37 |
| 52 Week High | $13.19 | $292.78 |
| Indicator | VRAX | MYSZ |
|---|---|---|
| Relative Strength Index (RSI) | 21.31 | 22.66 |
| Support Level | $0.15 | $0.37 |
| Resistance Level | $1.57 | $2.60 |
| Average True Range (ATR) | 0.17 | 0.07 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 10.47 | 2.36 |
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.